Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 103 Lung Neoplasms 39 Neoplasms 11 Neoplasm Metastasis 11 Colorectal Neoplasms 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Pancreatic Neoplasms 6 Mesothelioma, Malignant 5 Mesothelioma 5 Carcinoma 5 Ovarian Neoplasms 4 Meningeal Carcinomatosis 4 Melanoma 4 Colonic Neoplasms 4 Advanced Solid Tumors 4 Rectal Neoplasms 3 Adenocarcinoma of Lung 3 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Non-squamous Non-small Cell Lung Cancer 2 Neoplasms by Site 2 Lung Diseases 2 Gastrointestinal Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Pancreatic Ductal 2 Carcinoma, Bronchogenic 2 Bronchial Neoplasms 2 Brain Neoplasms 2

Interventions

pembrolizumab 2 Carboplatin 2 tislelizumab 1 cemiplimab 1 aflutinib 1 Pemetrexed 1 Docetaxel 1 Cisplatin 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Non-small Cell Lung Cancer × Pemetrexed × 90 days × Clear all

NCT06452277 2026-05-18

SOHO-02

Bayer

Phase 3 Recruiting

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡